OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Beyond classical benzodiazepines: novel therapeutic potential of GABAA receptor subtypes
Uwe Rudolph, Frédéric Knoflach
Nature Reviews Drug Discovery (2011) Vol. 10, Iss. 9, pp. 685-697
Open Access | Times Cited: 656

Showing 1-25 of 656 citing articles:

Crystal structure of a human GABAA receptor
Paul S. Miller, A.R. Aricescu
Nature (2014) Vol. 512, Iss. 7514, pp. 270-275
Open Access | Times Cited: 667

The Link between Depression and Chronic Pain: Neural Mechanisms in the Brain
Jiyao Sheng, Liu Shui, Yicun Wang, et al.
Neural Plasticity (2017) Vol. 2017, pp. 1-10
Open Access | Times Cited: 632

Autistic-like behaviour in Scn1a+/− mice and rescue by enhanced GABA-mediated neurotransmission
Sung Han, Chao Tai, Ruth E. Westenbroek, et al.
Nature (2012) Vol. 489, Iss. 7416, pp. 385-390
Open Access | Times Cited: 615

Autoantibodies to Synaptic Receptors and Neuronal Cell Surface Proteins in Autoimmune Diseases of the Central Nervous System
Josep Dalmau, Christian Geis, Francesc Graus
Physiological Reviews (2017) Vol. 97, Iss. 2, pp. 839-887
Open Access | Times Cited: 549

Alterations in Cortical Network Oscillations and Parvalbumin Neurons in Schizophrenia
Guillermo González‐Burgos, Raymond Y. Cho, David A. Lewis
Biological Psychiatry (2015) Vol. 77, Iss. 12, pp. 1031-1040
Open Access | Times Cited: 471

GABAA receptor signalling mechanisms revealed by structural pharmacology
Simonas Masiulis, Rooma Desai, Tomasz Uchański, et al.
Nature (2018) Vol. 565, Iss. 7740, pp. 454-459
Open Access | Times Cited: 467

50 years of hurdles and hope in anxiolytic drug discovery
Guy Griebel, Andrew Holmes
Nature Reviews Drug Discovery (2013) Vol. 12, Iss. 9, pp. 667-687
Open Access | Times Cited: 402

Developmental timing and critical windows for the treatment of psychiatric disorders
Oscar Marı́n
Nature Medicine (2016) Vol. 22, Iss. 11, pp. 1229-1238
Closed Access | Times Cited: 333

Cortical GABAergic Dysfunction in Stress and Depression: New Insights for Therapeutic Interventions
Manoela V. Fogaça, Ronald S. Duman
Frontiers in Cellular Neuroscience (2019) Vol. 13
Open Access | Times Cited: 311

GABAAreceptor signalling mechanisms revealed by structural pharmacology.
Simonas Masiulis, Rooma Desai, Tomasz Uchański, et al.
Nature (2019) Vol. 565, Iss. 7740, pp. 454-459
Closed Access | Times Cited: 308

Depression, anxiety and acute pain: links and management challenges
Athena Michaelides, Panagiotis Zis
Postgraduate Medicine (2019) Vol. 131, Iss. 7, pp. 438-444
Closed Access | Times Cited: 305

GABAA Receptor Subtypes: Therapeutic Potential in Down Syndrome, Affective Disorders, Schizophrenia, and Autism
Uwe Rudolph, Hanns Möhler
The Annual Review of Pharmacology and Toxicology (2013) Vol. 54, Iss. 1, pp. 483-507
Open Access | Times Cited: 292

Rapid‐acting antidepressant ketamine, its metabolites and other candidates: A historical overview and future perspective
Kenji Hashimoto
Psychiatry and Clinical Neurosciences (2019) Vol. 73, Iss. 10, pp. 613-627
Open Access | Times Cited: 286

The GABAA Receptor as a Therapeutic Target for Neurodevelopmental Disorders
Sien Braat, R. Frank Kooy
Neuron (2015) Vol. 86, Iss. 5, pp. 1119-1130
Open Access | Times Cited: 268

Zolpidem for insomnia
David J. Greenblatt, Thomas Roth
Expert Opinion on Pharmacotherapy (2012) Vol. 13, Iss. 6, pp. 879-893
Closed Access | Times Cited: 266

GABAA receptors: structure, function, pharmacology, and related disorders
Amr Ghit, Dina Assal, Ahmed S. Al‐Shami, et al.
Journal of Genetic Engineering and Biotechnology (2021) Vol. 19, Iss. 1, pp. 123-123
Open Access | Times Cited: 248

The direct actions of cannabidiol and 2-arachidonoyl glycerol at GABA A receptors
Tim Bakas, P.S. van Nieuwenhuijzen, S.O. Devenish, et al.
Pharmacological Research (2017) Vol. 119, pp. 358-370
Closed Access | Times Cited: 204

Neurogenetics of Aggressive Behavior: Studies in Rodents
Aki Takahashi, Klaus A. Miczek
Current topics in behavioral neurosciences (2013), pp. 3-44
Open Access | Times Cited: 203

An Emerging Circuit Pharmacology of GABAA Receptors
Elif Engin, Rebecca S. Benham, Uwe Rudolph
Trends in Pharmacological Sciences (2018) Vol. 39, Iss. 8, pp. 710-732
Open Access | Times Cited: 184

International Union of Basic and Clinical Pharmacology. CVI: GABAAReceptor Subtype- and Function-selective Ligands: Key Issues in Translation to Humans
Werner Sieghart, Miroslav M. Savić
Pharmacological Reviews (2018) Vol. 70, Iss. 4, pp. 836-878
Open Access | Times Cited: 175

GABAergic dysfunction in excitatory and inhibitory (E/I) imbalance drives the pathogenesis of Alzheimer's disease
Danlei Bi, Lang Wen, Zujun Wu, et al.
Alzheimer s & Dementia (2020) Vol. 16, Iss. 9, pp. 1312-1329
Closed Access | Times Cited: 151

SIRT3 mediates hippocampal synaptic adaptations to intermittent fasting and ameliorates deficits in APP mutant mice
Yong Liu, Aiwu Cheng, Yu-Jiao Li, et al.
Nature Communications (2019) Vol. 10, Iss. 1
Open Access | Times Cited: 150

A review on the traditional uses, phytochemistry, and pharmacological activities of clove basil (Ocimum gratissimum L.)
Ositadinma Chinyere Ugbogu, Okezie Emmanuel, Grace Oka Agi, et al.
Heliyon (2021) Vol. 7, Iss. 11, pp. e08404-e08404
Open Access | Times Cited: 106

Page 1 - Next Page

Scroll to top